澳柯玛(600336) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 2,205,112,404.42, a decrease of 13.80% compared to CNY 2,558,017,665.26 in the same period last year[4] - Net profit attributable to shareholders increased by 29.37% to CNY 41,358,438.67 from CNY 31,968,192.80 year-on-year[4] - The net profit after deducting non-recurring gains and losses rose by 47.13% to CNY 37,415,840.72 compared to CNY 25,429,904.00 in the previous year[4] - The basic earnings per share increased by 29.18% to CNY 0.0518 from CNY 0.0401 in the same period last year[4] - The weighted average return on equity improved by 0.41 percentage points to 1.68% from 1.27% year-on-year[4] - Net profit for Q1 2025 reached ¥41,245,530.59, an increase of 20.5% from ¥34,186,328.08 in Q1 2024[18] - Earnings per share for Q1 2025 was ¥0.0518, compared to ¥0.0401 in Q1 2024, reflecting a 29.9% increase[18] - Operating profit for Q1 2025 was ¥0.99 million, down from ¥12.05 million in Q1 2024, reflecting a significant decline[27] - Net profit for Q1 2025 was ¥3.82 million, compared to ¥12.77 million in Q1 2024, indicating a year-over-year decrease of 70.0%[27] Assets and Liabilities - Total assets at the end of Q1 2025 were CNY 8,037,204,157.66, an increase of 1.69% from CNY 7,903,714,439.89 at the end of the previous year[5] - The total assets as of the end of the reporting period amounted to ¥8,037,204,157.66, up from ¥7,903,714,439.89[14] - Total liabilities increased to ¥5,342,818,842.98 from ¥5,250,070,796.53, representing a rise of 1.8%[14] - The total liabilities decreased to CNY 2,933,324,952.18 from CNY 3,013,560,260.57 at the end of 2024[25] - The total equity attributable to shareholders increased to ¥2,481,660,285.07 from ¥2,440,805,705.67, reflecting a growth of 1.7%[14] - The total equity increased slightly to CNY 2,808,167,899.78 from CNY 2,803,659,633.37 at the end of 2024[25] Cash Flow - The net cash flow from operating activities was CNY -174,372,162.62, showing an improvement from CNY -225,519,080.92 in the previous year[4] - In Q1 2025, the cash inflow from operating activities was CNY 1,844,255,993.52, a decrease of 28.6% compared to CNY 2,581,593,350.15 in Q1 2024[20] - The cash inflow from investment activities was CNY 91,993,535.28, compared to CNY 2,516,086.60 in Q1 2024, marking a significant increase[21] - The net cash flow from investment activities was CNY 27,168,427.28, recovering from a negative CNY -48,283,659.94 in Q1 2024[21] - The cash inflow from financing activities was CNY 191,881,119.84, down 71.4% from CNY 670,082,041.50 in Q1 2024[21] - The net cash flow from financing activities was negative at CNY -57,897,127.18, contrasting with a positive CNY 372,136,519.85 in the previous year[21] - The total cash and cash equivalents at the end of Q1 2025 were CNY 576,276,110.77, down from CNY 651,094,300.93 at the end of Q1 2024[21] - Cash flow from operating activities for Q1 2025 was negative at -¥97.21 million, an improvement from -¥138.41 million in Q1 2024[29] - Cash flow from investing activities for Q1 2025 was positive at ¥54.90 million, compared to a negative cash flow of -¥14.87 million in Q1 2024[30] - Cash flow from financing activities for Q1 2025 was positive at ¥14.44 million, a decrease from ¥135.11 million in Q1 2024[30] - Total cash and cash equivalents at the end of Q1 2025 were ¥300.90 million, up from ¥267.71 million at the end of Q1 2024[30] Shareholder Information - The company reported a total of 51,609 ordinary shareholders at the end of the reporting period[9] - The largest shareholder, Qingdao Aokema Holdings Group Co., Ltd., holds 23.03% of the shares, totaling 183,812,152 shares[9] Government Subsidies and Expenses - The company received government subsidies amounting to CNY 1,609,500, which are closely related to its normal business operations[6] - Research and development expenses for Q1 2025 were ¥52,054,640.00, down from ¥58,743,999.61 in Q1 2024, a decrease of 11.5%[17] - Financial expenses for Q1 2025 were ¥3.21 million, significantly higher than ¥1.13 million in Q1 2024, indicating a rise of 184.1%[27] - Sales expenses increased slightly to ¥33.03 million in Q1 2025 from ¥31.97 million in Q1 2024, showing a 3.3% increase[27]